X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Orchid Chemicals with FDC LTD. - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ORCHID PHARMA LTD vs FDC LTD. - Comparison Results

ORCHID PHARMA LTD    Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ORCHID PHARMA LTD FDC LTD. ORCHID PHARMA LTD/
FDC LTD.
 
P/E (TTM) x -0.8 17.3 - View Chart
P/BV x 0.6 3.6 15.7% View Chart
Dividend Yield % 0.0 1.3 -  

Financials

 ORCHID PHARMA LTD   FDC LTD.
EQUITY SHARE DATA
    ORCHID PHARMA LTD
Sep-13
FDC LTD.
Mar-14
ORCHID PHARMA LTD/
FDC LTD.
5-Yr Chart
Click to enlarge
High Rs194144 135.2%   
Low Rs3579 44.3%   
Sales per share (Unadj.) Rs276.547.6 581.2%  
Earnings per share (Unadj.) Rs-79.27.6 -1,041.0%  
Cash flow per share (Unadj.) Rs-43.59.0 -482.2%  
Dividends per share (Unadj.) Rs02.25 0.0%  
Dividend yield (eoy) %02.0 0.0%  
Book value per share (Unadj.) Rs53.947.5 113.5%  
Shares outstanding (eoy) m70.45177.83 39.6%   
Bonus/Rights/Conversions ESOPBB-  
Price / Sales ratio x0.42.3 17.7%   
Avg P/E ratio x-1.414.6 -9.9%  
P/CF ratio (eoy) x-2.612.3 -21.3%  
Price / Book Value ratio x2.12.3 90.7%  
Dividend payout %029.6 0.0%   
Avg Mkt Cap Rs m8,06719,784 40.8%   
No. of employees `0002.8NA-   
Total wages/salary Rs m2,5271,221 207.0%   
Avg. sales/employee Rs Th6,956.1NM-  
Avg. wages/employee Rs Th902.5NM-  
Avg. net profit/employee Rs Th-1,993.0NM-  
INCOME DATA
Net Sales Rs m19,4778,459 230.3%  
Other income Rs m407394 103.5%   
Total revenues Rs m19,8848,852 224.6%   
Gross profit Rs m1,1032,070 53.3%  
Depreciation Rs m2,519249 1,011.3%   
Interest Rs m5,22731 16,855.2%   
Profit before tax Rs m-6,2362,184 -285.6%   
Minority Interest Rs m200-   
Prior Period Items Rs m0-225 0.0%   
Extraordinary Inc (Exp) Rs m5110-   
Tax Rs m-125606 -20.7%   
Profit after tax Rs m-5,5801,353 -412.4%  
Gross profit margin %5.724.5 23.1%  
Effective tax rate %2.027.7 7.2%   
Net profit margin %-28.716.0 -179.1%  
BALANCE SHEET DATA
Current assets Rs m11,0144,355 252.9%   
Current liabilities Rs m32,0601,792 1,789.2%   
Net working cap to sales %-108.130.3 -356.6%  
Current ratio x0.32.4 14.1%  
Inventory Days Days9544 213.4%  
Debtors Days Days3425 136.0%  
Net fixed assets Rs m29,4403,025 973.2%   
Share capital Rs m705179 394.5%   
"Free" reserves Rs m2,0438,243 24.8%   
Net worth Rs m3,8008,453 45.0%   
Long term debt Rs m9,01811 84,279.4%   
Total assets Rs m46,51010,557 440.6%  
Interest coverage x-0.271.4 -0.3%   
Debt to equity ratio x2.40 187,482.3%  
Sales to assets ratio x0.40.8 52.3%   
Return on assets %-0.813.1 -5.8%  
Return on equity %-146.916.0 -917.4%  
Return on capital %-3.723.5 -15.9%  
Exports to sales %37.913.3 284.6%   
Imports to sales %22.63.3 676.6%   
Exports (fob) Rs m7,3781,126 655.4%   
Imports (cif) Rs m4,406283 1,558.0%   
Fx inflow Rs m7,5131,146 655.6%   
Fx outflow Rs m5,649355 1,589.9%   
Net fx Rs m1,865791 235.8%   
CASH FLOW
From Operations Rs m1,6821,485 113.3%  
From Investments Rs m-9,860-620 1,591.7%  
From Financial Activity Rs m6,644-753 -882.9%  
Net Cashflow Rs m-1,535113 -1,360.8%  

Share Holding

Indian Promoters % 32.3 68.9 46.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.6 4.7 97.9%  
FIIs % 3.3 7.5 44.0%  
ADR/GDR % 4.6 0.0 -  
Free float % 55.3 19.0 291.1%  
Shareholders   84,811 23,730 357.4%  
Pledged promoter(s) holding % 54.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ORCHID PHARMA LTD With:   STERLING BIOTECH  SANOFI INDIA  ALEMBIC PHARMA  SHASUN PHARMA  NOVARTIS  

Compare ORCHID PHARMA LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Flat Note; Coal India Stock Rallies 4.2%(Closing)

Indian share markets finished some selling pressure in the final hour of trade to finish flat amid weak European markets.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ORCHID PHARMA LTD SHARE PRICE


Aug 17, 2017 (Close)

TRACK ORCHID PHARMA LTD

  • Track your investment in ORCHID PHARMA LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ORCHID PHARMA LTD

ORCHID PHARMA LTD - GLENMARK PHARMA COMPARISON

COMPARE ORCHID PHARMA LTD WITH

MARKET STATS